All News #Library
Sciences
Dizal Sunvozertinib Egfr Exon 20: Biomarker Nsclc Mutation Treatment Analysis
24 May 2024 //
PR NEWSWIRE
Dizal reports positive Phase I data for breast cancer therapy
06 Sep 2022 //
CLINICALTRIALSARENA

Market Place
Sourcing Support